Skip to main content

Month: August 2020

Brain Scientific’s Expansion Relocates Its Headquarters to Bohemia, New York

NEW YORK, NY, Aug. 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, announced an expansion of their facilities via a headquarter relocation to Bohemia, New York in central Long Island. The additional space will give the Brain Scientific team the ability to conduct more comprehensive and advance in-house R&D and product development.Commenting on the planned headquarter move, Boris Goldstein, Chairman of the Board and Executive Vice President stated, “I believe this relocation of our headquarters to Bohemia is a strategic decision which will put us in a position of increased growth. The facility will house the space and staff needed to accommodate the demand of our existing devices as well as the development of new, innovative products.”The...

Continue reading

Verde Sales Grow 202% With Gross Margin Over 60% in the Second Quarter of 2020

(All figures are in Canadian dollars, unless otherwise expressed. Exchange rate in Q2 2020: 1.00 CAD = 3.598 BRL)BELO HORIZONTE, Brazil, Aug. 17, 2020 (GLOBE NEWSWIRE) — Verde AgriTech Plc (TSX: “NPK”) (OTCQB: “AMHPF”) (“Verde” or the “Company”) is pleased to announce its financial results for the second quarter, ended June 30, 2020 (“Q2 2020”).Q2 2020 Financial HighlightsThe Company recognised revenue of $2,492,586, an increase of 87% compared to $1,329,127 in the second quarter of 2019 (“Q2 2019”).Production increased by 139% with a total of 80,490 tonnes mined, compared to 33,671 tonnes in Q2 2019.Sales increased by 202% with a total of 71,183 tonnes sold, compared to 23,600 tonnes in Q2 2019.The Company generated a net profit of $443,525, compared to a net loss of $222,657 in Q2 2019.Gross margin increased by 12%, with...

Continue reading

O3 Mining Starts Drilling On Malartic Property

TORONTO, Aug. 17, 2020 (GLOBE NEWSWIRE) — O3 Mining Inc. (TSX.V:OIII) (“O3 Mining” or the “Corporation”) is pleased to announce the commencement of drilling on its Malartic property situated midway between the towns of Val D’Or and Malartic, Quebec, and 12 kilometres from the Canadian Malartic Mine.  Following the completion of the summer drill program at East Cadillac, one drill has been mobilized to the Malartic property to expand existing zones along strike and at depth and to explore regional targets. The drilling will focus on the extensions of the Orion 8 (historic production of 22,252 oz Au at 5.82 g/t), Gold Hawk, Malartic H, North Shear and North-North zones located near the Marban deposit, where the company is currently conducting a Preliminary Economic Assessment (PEA).  Additionally, regional...

Continue reading

Silver Bull Enters Into an Option Agreement to Acquire the Beskauga Copper-Gold Project in Kazakhstan

VANCOUVER, British Columbia, Aug. 17, 2020 (GLOBE NEWSWIRE) — Silver Bull Resources, Inc. (OTCQB: SVBL, TSX: SVB) (“Silver Bull”) is pleased to announce it has entered into an option to purchase agreement with Copperbelt AG (“Copperbelt”), a private mineral exploration company registered in Zug, Switzerland, to acquire a 100% interest in their Beskauga copper-gold project located in North Eastern Kazakhstan. Highlights of the AgreementOn execution of the agreement Silver Bull paid Copperbelt US$30,000. An additional US$40,000 will be paid to Copperbelt after due diligence on the Beskauga property is completed to Silver Bull’s satisfaction. Silver Bull will have a 60 day due diligence period which will commence after the Company has been able to access the Beskauga property in a matter that complies with governmental recommendations...

Continue reading

Aya Gold & Silver – First 100 Days Corporate Update

Montreal, Quebec, Aug. 17, 2020 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA) (“Aya” or the “Corporation”) is pleased to provide an update on its first 100 days of operations since the change of management disclosed in its press release issued on April 24th, 2020.Operations Update:A President and General Manager was appointed to Compagnie Minière Maya Maroc (“CMMM”), the Corporation’s wholly owned subsidiary in May of this year and quickly reviewed the ongoing operations. Together with new management and current employees, a maintenance plan was presented and approved by the Board of Directors of the Corporation. The maintenance plan includes mining equipment, tailings facilities, living quarters, flotation plant, cyanidation plant and surrounding infrastructure, which will undergo significant repair in order to improve...

Continue reading

Progressive Care Reports Q2 2020 Financials: Sales Up 32%, Over $2M in Cash on Hand

MIAMI, FL, Aug. 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for the three months and six months ended June 30, 2020. Read full releaseConsolidated net revenues for the three months ended June 30 totaled $9.2 million (for the six months ended June 30, $18.3 million), representing year-over-year growth of 32% (and 50% for the six-month period) compared to comparable periods in 2019Prescriptions filled in Q2 topped 126,000 (and 258,000 in the six-month period), representing year-over-year growth of 23% in Q2 2020 (and 38% for the six-month period) compared to comparable periods in 2019Income from services related to 340B Covered Entities increased...

Continue reading

Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology

DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that new data that add to the growing body of knowledge on VASCEPA® (icosapent ethyl) in patients at risk for major adverse cardiovascular events will be presented at ESC Congress 2020, the annual meeting of the European Society of Cardiology (ESC), being held virtually from August 29 – September 1, 2020. These new findings will be presented in one Late-Breaking Science presentation and four rapid fire abstract and e-poster presentations from a variety of academic collaborators based on research or analyses supported by Amarin.    “Cardiovascular disease is an ever-increasing global challenge commanding both attention and action,” said Craig Granowitz, M.D., Ph.D., Amarin’s senior vice president and...

Continue reading

Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months

GAITHERSBURG, Md., Aug. 17, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the extension of the shelf life of NARCAN® (naloxone HCl) Nasal Spray from 24 months to 36 months. Narcan Nasal Spray was the first intranasal form of naloxone approved by FDA and Health Canada for the emergency treatment of known or suspected opioid overdose.“Emergent is pleased to receive FDA approval of the shelf life extension for NARCAN® Nasal Spray,” said Doug White, SVP and devices business unit head at Emergent. “This is an example of our continued efforts to innovate and improve product features designed to address the needs of patients, consumers, health care providers, pharmacists, and first responders.”In early July, the company launched the Generation...

Continue reading

BriaCell Presents Clinical and Scientific Findings at the Annual Symposium of Society of Surgical Oncology 2020

Preliminary safety and efficacy data are being presented today from the clinical trials of Bria-IMT™ in combination with immune checkpoint (PD-1) inhibitors in advanced breast cancer patients.Clinical responses and disease control—without serious side effects—in heavily pre-treated patients with metastatic breast cancer seen with lead candidate, Bria-IMT™, in combination with pembrolizumab (KEYTRUDA®; manufactured by Merck & Co., Inc.), a PD-1 inhibitor.Higher levels of immune system activation were directly related to higher incidences of tumor reduction and higher rates of disease control and clinical benefit in patients with advanced breast cancer.BERKELEY, Calif., and VANCOUVER, British Columbia, Aug. 17, 2020 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage...

Continue reading

PureGold Resumes Operations at Site

VANCOUVER, British Columbia, Aug. 17, 2020 (GLOBE NEWSWIRE) — Pure Gold Mining Inc. (TSX-V: PGM, LSE: PUR) (“PureGold” or the “Company”) is pleased to report that the forest fire which had been active in the area south of the town of Red Lake is now under control and the evacuation order for the municipality of Red Lake has been rescinded. Power and access has been restored to site and the Company is transitioning to a full resumption of mine activities. Both surface and underground inspections have been completed and confirm that there is no damage to infrastructure or equipment at the mine site. The temporary shut down had no material impact on our development schedule with first gold pour expected in Q4 2020.“The immediate response and tireless efforts of the Ministry of Natural Resources and Forestry contained the fire, protecting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.